- Home
- RELL vs CRVO Comparison
RELL vs CRVO Comparison
Compare RELL & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RELL
- CRVO
- Stock Information
- Founded
- RELL 1947
- CRVO 2001
- Country
- RELL United States
- CRVO United States
- Employees
- RELL N/A
- CRVO N/A
- Industry
- RELL Electronic Components
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- RELL Technology
- CRVO Health Care
- Exchange
- RELL Nasdaq
- CRVO Nasdaq
- Market Cap
- RELL 169.6M
- CRVO 67.4M
- IPO Year
- RELL N/A
- CRVO N/A
- Fundamental
- Price
- RELL $10.78
- CRVO $7.05
- Analyst Decision
- RELL
- CRVO Strong Buy
- Analyst Count
- RELL 0
- CRVO 6
- Target Price
- RELL N/A
- CRVO $19.17
- AVG Volume (30 Days)
- RELL 164.2K
- CRVO 110.5K
- Earning Date
- RELL 10-08-2025
- CRVO 11-12-2025
- Dividend Yield
- RELL 2.21%
- CRVO N/A
- EPS Growth
- RELL N/A
- CRVO N/A
- EPS
- RELL 0.01
- CRVO N/A
- Revenue
- RELL $209,791,000.00
- CRVO $7,776,968.00
- Revenue This Year
- RELL $4.72
- CRVO N/A
- Revenue Next Year
- RELL $14.93
- CRVO N/A
- P/E Ratio
- RELL $886.64
- CRVO N/A
- Revenue Growth
- RELL 6.17
- CRVO N/A
- 52 Week Low
- RELL $7.57
- CRVO $1.80
- 52 Week High
- RELL $15.51
- CRVO $16.94
- Technical
- Relative Strength Index (RSI)
- RELL 51.58
- CRVO 40.12
- Support Level
- RELL $10.64
- CRVO $6.70
- Resistance Level
- RELL $11.18
- CRVO $7.15
- Average True Range (ATR)
- RELL 0.48
- CRVO 0.38
- MACD
- RELL -0.08
- CRVO -0.02
- Stochastic Oscillator
- RELL 14.48
- CRVO 20.91
About RELL Richardson Electronics Ltd.
Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. The company's segment includes Power and Microwave Technologies, Green Energy Solutions, Canvys, and Healthcare. The company generates the majority of its revenue from the Power and Microwave Technologies segment, which includes the power grid and microwave tube business and RF, Wireless and Power technologies.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.